MSN 571 PHARM-MIDTERM-FINAL EXAN Q & A ALL ANSWERS 100% CORRECT LATEST UPDATE 2022/2023 GRADED A+

MSN 571 PHARM-MIDTERM-FINAL EXAN Q & A ALL
ANSWERS 100% CORRECT LATEST UPDATE 2022/2023
GRADED A+

 Fluoroquinolone antibiotics are most likely indicating in
which of the conditions Asthma
Genital
infections
Follicular
conjunctivitis
GERD
 Which of the following is most likely an intervention for otitis media?

Amoxicillin
Aspirin
Immunoglob
ulins
Corticostero
ids
 Which of the following best classifies penicillin,
cephalosporins, and Protein synthesis
inhibitors
Mycolic acid synthesis
inhibitors RNA
synthesis
Cell wall inhibitors

 Lower doses of sublingual nitroglycerin can be used effectively
because
MSN 571 PHARM-MIDTERM-FINAL EXAN Q & A ALL
ANSWERS 100% CORRECT LATEST UPDATE 2022/2023
GRADED A+

,MSN 571 PHARM-MIDTERM-FINAL EXAN Q & A ALL
ANSWERS 100% CORRECT LATEST UPDATE 2022/2023
GRADED A+
It bypasses the liver

The potency is 100 times higher

It does not need to be absorbed into
the bloodstream It is not catabolized
down by gastric acids
 Which term refers to the ratio between a drugs therapeutic
effects and its toxic effects? Cumulative effect
Therapeutic index

Tolera
nce
Affinit
y
 In geriatric patients the percentage of body fat is increased.
What are the pharmacologic implications of the physiologic
change?
A lipid soluble medication will be eliminated more quickly and
not work as well Absorption of lipid soluble drugs is impaired
in older adults.
The bioavailability of the lipid soluble drug will be increased in
older adults

A lipid soluble medication will accumulate in fat tissue and its
duration of action may be prolonged

MSN 571 PHARM-MIDTERM-FINAL EXAN Q & A ALL
ANSWERS 100% CORRECT LATEST UPDATE 2022/2023
GRADED A+

,MSN 571 PHARM-MIDTERM-FINAL EXAN Q & A ALL
ANSWERS 100% CORRECT LATEST UPDATE 2022/2023
GRADED A+
 A patient diagnosed with otitis externa and taking a
fluoroquinolone with glucocorticoid benefit is taking the
medication together you reply
The glucocorticoid reduces the swelling caused by the inflammation
and ear infection

The glucocorticoid decreased likelihood of antibiotic resistant

The glucocorticoid decreases the adverse effects of the
fluoroquinolone




MSN 571 PHARM-MIDTERM-FINAL EXAN Q & A ALL
ANSWERS 100% CORRECT LATEST UPDATE 2022/2023
GRADED A+

, MSN 571 PHARM-MIDTERM-FINAL EXAN Q & A ALL
ANSWERS 100% CORRECT LATEST UPDATE 2022/2023
GRADED A+

The two medications are contraindicated for use together



 A two year old child presents to the clinic with arthralgia and
fever in the last tympanic membrane is erythematous and bulging
the right TMS is perforated and draining the child’s parent states
“this is fifth year infection this year “what can we do? what action
will the provider take to address to Childs ear problems
Prescribe amoxicillin/clavulanate and refer the child to an
otolaryngologist??? I THINK THIS IS CORRECT
Prescribe both ceftriaxone (Rocephin) IM with benzocaine ear
drops for pain

 A patient is diagnosed with otitis externa. Comorbidities include
diabetes mellitus, hypertension, and advanced multiple sclerosis.
Which type of education regarding medication administration
would you provide? page 1304 repeat #20
The oral administration of a prescription for
hydrocortisone/neomycin/polymyxin B combination solution
The oral administration of a prescription for fluoroquinolone

The administration of topical medication for a prescription of
alcohol plus acetic acid s solution
The administration of topical combination for a prescription of
fluoroquinolone/glucocorticoid combination solution

MSN 571 PHARM-MIDTERM-FINAL EXAN Q & A ALL
ANSWERS 100% CORRECT LATEST UPDATE 2022/2023
GRADED A+